Search
for
Sort by
Research 691–720 of 1000+
- Utility of laboratory testing in patients with female pattern hair loss
- PC039: Adverse effects at the level of marginal periodontium secondary to Finasteride administration
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- The dermatoscope in the hair clinic: Trichoscopy of scarring and nonscarring alopecia
- Body hair transplantation in vitiligo
- Pseudofolliculitis barbae; current treatment options
- Prevalence of polycystic ovary syndrome under NIH criteria among the tenth-grade Chinese schoolgirls in Guangzhou area: a cross-sectional epidemiological survey
- Malate-based polyester chemically shielded metal-phenolic networks coated artificial hair fibers with long-lasting antimicrobial and anti-inflammatory performance
- Beyond Monotherapy: Adjunctive Treatments with Minoxidil for Androgenetic Alopecia
- The Pathogenesis of Primary Cicatricial Alopecias
- Cosmetic Treatment Using Botulinum Toxin in the Oral and Maxillofacial Area: A Narrative Review of Esthetic Techniques
- Disorders of Keratinization
- Topical ALA-Photodynamic Therapy for Acne Can Induce Apoptosis of Sebocytes and Down-regulate Their TLR-2 and TLR-4 Expression
- Basaloid follicular hamartoma, total body hair loss and SLE
- Alopécie frontale fibrosante : à propos de trois cas pédiatriques
- β1 Integrins with Individually Disrupted Cytoplasmic NPxY Motifs Are Embryonic Lethal but Partially Active in the Epidermis
- Malignant Melanoma and Its Stromal Nonimmune Microecosystem
- Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of Frontal Fibrosing Alopecia
- Hidradenitis suppurativa: A comparison of guidelines
- In vitro, ex vivo, and clinical evaluation of anti‐aging gel containing EPA and CBD
- Staphylococcus lugdunensis and Trichophyton tonsurans Infection in Synthetic Hair Implants.
- LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- IgG/IgA pemphigus with differing regional presentations
- Epidemiology and Haemato-Biochemical Changes in Mange Infested Camels
- 051 γδ T cells as novel players in alopecia areata pathobiology: Vδ1 + T lymphocytes may recognize “stressed” hair follicle keratinocytes, leading to IFNγ-dependent hair follicle dystrophy and immune privilege collapse
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant patients using a modified delphi process
- Alopecia Areata in Sub-Saharan Africa: A Scoping Review Protocol on Epidemiology, Clinical Presentation, Burden, Treatment, and Evidence Gaps.